203 related articles for article (PubMed ID: 34904202)
1. Engineering a Remedy to Modulate and Optimize Biopharmaceutical Properties of Rebamipide by Synthesizing New Cocrystal: In Silico and Experimental Studies.
Jindal A; Singh R; Tomar S; Dureja J; Karan M; Chadha R
Pharm Res; 2021 Dec; 38(12):2129-2145. PubMed ID: 34904202
[TBL] [Abstract][Full Text] [Related]
2. Cocrystals of diacerein: Towards the development of improved biopharmaceutical parameters.
Tomar S; Chakraborti S; Jindal A; Grewal MK; Chadha R
Int J Pharm; 2020 Jan; 574():118942. PubMed ID: 31830577
[TBL] [Abstract][Full Text] [Related]
3. Formulation of solid dispersion of rebamipide evaluated in a rat model for improved bioavailability and efficacy.
Tung NT; Park CW; Oh TO; Kim JY; Ha JM; Rhee YS; Park ES
J Pharm Pharmacol; 2011 Dec; 63(12):1539-47. PubMed ID: 22060284
[TBL] [Abstract][Full Text] [Related]
4. Supramolecular Cocrystals of Gliclazide: Synthesis, Characterization and Evaluation.
Chadha R; Rani D; Goyal P
Pharm Res; 2017 Mar; 34(3):552-563. PubMed ID: 28035627
[TBL] [Abstract][Full Text] [Related]
5. Pharmaceutical Cocrystals of Famotidine: Structural and Biopharmaceutical Evaluation.
Jindal A; Prashar M; Dureja J; Dhingra N; Chadha K; Karan M; Chadha R
J Pharm Sci; 2022 Oct; 111(10):2788-2798. PubMed ID: 35508209
[TBL] [Abstract][Full Text] [Related]
6. Daidzein cocrystals: An opportunity to improve its biopharmaceutical parameters.
Bhalla Y; Chadha K; Chadha R; Karan M
Heliyon; 2019 Nov; 5(11):e02669. PubMed ID: 31763466
[TBL] [Abstract][Full Text] [Related]
7. Physicochemical, pharmacokinetic and pharmacodynamic evaluations of novel ternary solid dispersion of rebamipide with poloxamer 407.
Park CW; Tung NT; Rhee YS; Kim JY; Oh TO; Ha JM; Chi SC; Park ES
Drug Dev Ind Pharm; 2013 Jun; 39(6):836-44. PubMed ID: 22510064
[TBL] [Abstract][Full Text] [Related]
8. Development of a rebamipide solid dispersion system with improved dissolution and oral bioavailability.
Pradhan R; Tran TH; Choi JY; Choi IS; Choi HG; Yong CS; Kim JO
Arch Pharm Res; 2015 Apr; 38(4):522-33. PubMed ID: 24895145
[TBL] [Abstract][Full Text] [Related]
9. The solid state of rebamipide: preparation, characterization, and dissolution.
Jeon SH; Sohn YT
Arch Pharm Res; 2016 Apr; 39(4):508-515. PubMed ID: 26897596
[TBL] [Abstract][Full Text] [Related]
10. Indomethacin-saccharin cocrystal: design, synthesis and preliminary pharmaceutical characterization.
Basavoju S; Boström D; Velaga SP
Pharm Res; 2008 Mar; 25(3):530-41. PubMed ID: 17703346
[TBL] [Abstract][Full Text] [Related]
11. Novel Aceclofenac Cocrystals with l-Cystine: Virtual Coformer Screening, Mechanochemical Synthesis, and Physicochemical Investigations.
Kumar S; Gupta A; Prasad R; Singh S
Curr Drug Deliv; 2021; 18(1):88-100. PubMed ID: 32807053
[TBL] [Abstract][Full Text] [Related]
12. Solid state manipulation of lornoxicam for cocrystals--physicochemical characterization.
Nijhawan M; Santhosh A; Babu PR; Subrahmanyam CV
Drug Dev Ind Pharm; 2014 Sep; 40(9):1163-72. PubMed ID: 23829186
[TBL] [Abstract][Full Text] [Related]
13. Pharmaceutical Cocrystal of Piroxicam: Design, Formulation and Evaluation.
Panzade P; Shendarkar G; Shaikh S; Balmukund Rathi P
Adv Pharm Bull; 2017 Sep; 7(3):399-408. PubMed ID: 29071222
[No Abstract] [Full Text] [Related]
14. Synthon Approach in Crystal Engineering to Modulate Physicochemical Properties in Organic Salts of Chlorpropamide.
Menon AM; Sidhartha NN; Shruti I; Suresh A; Meena R; Dikundwar AG; Chopra D
Mol Pharm; 2024 Jun; 21(6):2894-2907. PubMed ID: 38688017
[TBL] [Abstract][Full Text] [Related]
15. Oral absorption and pharmacokinetics of rebamipide and rebamipide lysinate in rats.
Shin BS; Kim CH; Jun YS; Yoon CH; Rho JI; Lee KC; Han HS; Yoo SD
Drug Dev Ind Pharm; 2004 Sep; 30(8):869-76. PubMed ID: 15521332
[TBL] [Abstract][Full Text] [Related]
16. Pharmaceutical Cocrystal: A Novel Approach to Tailor the Biopharmaceutical Properties of a Poorly Water Soluble Drug.
Srivastava D; Fatima Z; Kaur CD; Tulsankar SL; Nashik SS; Rizvi DA
Recent Pat Drug Deliv Formul; 2019; 13(1):62-69. PubMed ID: 30848223
[TBL] [Abstract][Full Text] [Related]
17. Glibenclamide-malonic acid cocrystal with an enhanced solubility and bioavailability.
Srivastava D; Fatima Z; Kaur CD; Mishra A; Nashik SS; Rizvi DA; Prasad R
Drug Dev Ind Pharm; 2022 Aug; 48(8):417-424. PubMed ID: 36073946
[TBL] [Abstract][Full Text] [Related]
18. Improved pharmaceutical properties of ritonavir through co-crystallization approach with liquid-assisted grinding method.
Chaudhari KR; Savjani JK; Savjani KT; Shah H
Drug Dev Ind Pharm; 2021 Oct; 47(10):1633-1642. PubMed ID: 35156497
[TBL] [Abstract][Full Text] [Related]
19. Chrysin cocrystals: Characterization and evaluation.
Chadha R; Bhalla Y; Nandan A; Chadha K; Karan M
J Pharm Biomed Anal; 2017 Feb; 134():361-371. PubMed ID: 27894779
[TBL] [Abstract][Full Text] [Related]
20. A novel strategy for pharmaceutical cocrystal generation without knowledge of stoichiometric ratio: myricetin cocrystals and a ternary phase diagram.
Hong C; Xie Y; Yao Y; Li G; Yuan X; Shen H
Pharm Res; 2015 Jan; 32(1):47-60. PubMed ID: 24939640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]